Geriatrics: sleep disorders and aging

The New England Journal of Medicine
P N PrinzM J Thorpy

Abstract

No abstract listed.

References

Apr 5, 1979·The New England Journal of Medicine·F SolomonW B Mendelson
Apr 1, 1978·Clinical Pharmacology and Therapeutics·M M ReidenbergJ Cheripko
Jan 1, 1979·Archives of General Psychiatry·D F KripkeE C Hammond
May 1, 1976·Social Science & Medicine·I KaracanR L Williams
Jan 1, 1990·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·J M Siegel
Jan 1, 1989·The American Journal of Psychiatry·B V ReiflerP McLean
Mar 2, 1989·The New England Journal of Medicine·Z J Lipowski
Aug 3, 1989·The New England Journal of Medicine·S C MontamatR E Vestal
Nov 1, 1989·Neurology·A Culebras, J T Moore
Apr 20, 1985·Lancet·M KoskenvuoK Heikkilä
Aug 1, 1987·Journal of Clinical Psychopharmacology·S P RooseJ T Bigger
Jun 1, 1987·The Gerontologist·D BlazerL K George
Sep 1, 1986·Acta Psychiatrica Scandinavica·D H AveryO J Rafaelsen
Apr 3, 1987·JAMA : the Journal of the American Medical Association·C H SchenckM W Mahowald
Mar 1, 1986·Neurobiology of Aging·M V VitielloP N Prinz
Jul 1, 1985·Journal of Gerontology·S Ancoli-IsraelO J Kaplan
Jan 1, 1969·The British Journal of Psychiatry : the Journal of Mental Science·S A Lewis
May 1, 1969·The Journal of Nervous and Mental Disease·E Kahn, C Fisher
May 1, 1970·Comprehensive Psychiatry·E KahnL Lieberman
Nov 1, 1972·Journal of Applied Physiology·C M WingetP B Mack
Jun 1, 1967·Journal of Abnormal Psychology·L J Monroe
Jun 1, 1967·Journal of Psychiatric Research·I FeinbergN Heller
Sep 1, 1984·Journal of Gerontology·P N PrinzJ B Halter
May 1, 1984·Journal of Gerontology·H ZepelinG K Zammit
Apr 22, 1982·The New England Journal of Medicine·R C VeithJ L Ritchie
Jan 1, 1982·Neurobiology of Aging·E D WeitzmanJ C Zimmerman
Jan 1, 1982·Neurobiology of Aging·M A CarskadonW C Dement
Oct 1, 1981·Clinical Pharmacology and Therapeutics·D J GreenblattR I Shader
Jan 1, 1964·American Journal of Public Health and the Nation's Health·E C HAMMOND
Apr 29, 1966·Science·H P RoffwargW C Dement

❮ Previous
Next ❯

Citations

Dec 10, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergK Karlsen
Jan 1, 1992·Psychopharmacology·M Lader
Apr 1, 1994·Aging : Clinical and Experimental Research·I RäihäL Sourander
Oct 1, 1993·Physiology & Behavior·A Wauquier
Oct 1, 1995·Pharmacology, Biochemistry, and Behavior·J R McCartenJ P Cleary
Mar 1, 1993·Experimental Gerontology·T H MonkD J Kupfer
Sep 1, 1996·Journal of Clinical Epidemiology·G E SimonE Wagner
May 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·G HajakE Rüther
Jun 10, 2005·Journal of the Neurological Sciences·Kazuo AbeSabro Sakoda
Mar 23, 2004·Sleep Medicine·Stefania Brotini, Gian Luigi Gigli
Sep 22, 1998·Electroencephalography and Clinical Neurophysiology·C L EhlersV J Grochocinski
Oct 18, 2000·European Journal of Pharmacology·H L FehmJ Born
Mar 1, 1997·The Psychiatric Clinics of North America·D G Folks, W C Fuller
Jan 24, 1998·Clinical Psychology Review·M J Karel
Sep 13, 2000·Clinical Psychology Review·J MartinS Ancoli-Israel
Jul 1, 1997·Experimental Gerontology·M A Hofman
Apr 6, 2004·Sleep Medicine Reviews·Paul Montgomery, Jane Dennis
Nov 1, 2003·Sleep Medicine·Kirsti MartikainenIlkka Vuori
Jun 18, 2003·Respiratory Physiology & Neurobiology·Lyle J Palmer, Susan Redline
Sep 18, 2001·Journal of the American Geriatrics Society·M CriccoD J Foley
Jun 13, 1991·The New England Journal of Medicine·D J GreenblattR I Shader
Jul 25, 1991·The New England Journal of Medicine·A Kales
Apr 2, 1992·The New England Journal of Medicine·A I Neugut
Sep 29, 1994·The New England Journal of Medicine·M E TinettiR I Horwitz
Jan 31, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Alvin M Matsumoto
Feb 6, 1999·Journal of Clinical Psychopharmacology·B PerrasH Lorenz Fehm
Jan 25, 2003·Journal of Clinical Psychopharmacology·Boris PerrasHorst Lorenz Fehm
Dec 10, 2009·Psychosomatic Medicine·Charles F ReynoldsEric A Nofzinger
Apr 1, 1994·Journal of the American Academy of Nurse Practitioners·J E Johnston
Jan 6, 2012·Journal of Environmental and Public Health·Charumathi SabanayagamR Turner Goins
Sep 10, 2009·Gerontology·Ariel B Neikrug, Sonia Ancoli-Israel
Jan 30, 2003·Psychosomatic Medicine·Mary Amanda DewCharles F Reynolds
Feb 24, 2001·Aging : Clinical and Experimental Research·J P JanssensJ P Michel
Apr 11, 2013·Respiratory Physiology & Neurobiology·Peter M Lalley
Nov 14, 1998·Journal of Gerontological Nursing·P A TabloskiE B Thoman
Jun 20, 2008·Journal of Gerontological Nursing·Kathy Missildine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.